BUREN | China Practice Newsletter | November 2026

Stay up to date with our BUREN China Practice Newsletter!

Doing business in or with China requires staying informed about an evolving legal and regulatory landscape. New legislation and regulatory developments can have significant implications for international businesses, making it essential to understand both the legal requirements and their practical impact.

Our China Practice team closely monitors these developments to help you stay informed and prepared. In this latest edition, we highlight two key updates: the potential consequences of enforcement proceedings for foreign legal representatives of Chinese companies, including restrictions on travel and expenditure, and China's revised Good Clinical Practice rules, which introduce enhanced requirements for accountability, risk-based quality management and data governance in clinical trials.

We hope you find this edition both informative and practical. If any of these developments are relevant to your business, our team would be pleased to discuss them with you.

Below you will find the link to our latest newsletter.

BUREN | China Practice Newsletter | November 2026